Clinical Trial Update: A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165) [Phase 1]

View source ↗

Summary

This Phase 1 study assessed bioequivalence between aprepitant and fosaprepitant and evaluated the effect of food on aprepitant bioavailability; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 1 | Status: COMPLETED | Results posted: 2010-06-30